Class II · Moderate risk Terminated
Human Chorionic Gonadotropin 5
Reason Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.
FDA Drug Recalls
14,450 recalls · Class II, newest first
Class II · Moderate risk Terminated
Human Chorionic Gonadotropin 2
Reason Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.
Class II · Moderate risk Terminated
Human Chorionic Gonadotropin 500 iu Orally Disintegrating Tablets
Reason Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.
Class II · Moderate risk Terminated
Estriol 0.1%
Reason Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.
Class II · Moderate risk Terminated
Chloramphenicol 500 mg Sulfamethoxazole 500 mg Amphotericin 50 mg…
Reason Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.
Class II · Moderate risk Terminated
Chloramphenicol 500 mg Amphotericin 50 mg Otic Powder packaged in jars
Reason Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.
Class II · Moderate risk Terminated
Chloramphenicol 50 mg/ Sulfamethoxazole 50 mg/ Amphotericin-B 5 mg capsules
Reason Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.
Class II · Moderate risk Terminated
Bi-Est
Reason Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.
Class II · Moderate risk Terminated
Benzo/Lido/Tetracaine 20%-8%-8% Topical Cream packaged in jars
Reason Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.
Class II · Moderate risk Terminated
Benzocaine 20%
Reason Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.
Class II · Moderate risk Terminated
Benzocaine 20%
Reason Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.
Class II · Moderate risk Terminated
Arginine 150 mg/ Lysine HCl 50 mg/ Glutamine 200 mg/g Topical…
Reason Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.
Class II · Moderate risk Terminated
Anastrozole SR 1 mg Capsules
Reason Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.
Class II · Moderate risk Terminated
Amphotericin 60 mg/Chloramphenicol 600 mg/Hydrocortisone 10 mg…
Reason Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.
Class II · Moderate risk Terminated
Anastrozole 0.5 mg Capsules
Reason Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.
Class II · Moderate risk Terminated
0.9% Sodium Chloride Injection
Reason Lack of Assurance of Sterility
Class II · Moderate risk Terminated
Liothyronine Sodium Tablets
Reason Failed Dissolution Specifications.
Class II · Moderate risk Terminated
Clozapine Tablets USP
Reason Failed Tablet/Capsule Specifications; potential presence of broken tablets.
Class II · Moderate risk Terminated
Maximum Strength Zephrex-D
Reason Microbial Contamination of Non-Sterile Products
Class II · Moderate risk Terminated
Extra Strength Naturally HL Hemorrhoid Numbing with Lidocaine
Reason GMP Deviations: inadequate manufacturing control processes
Class II · Moderate risk Terminated
Extra Strength Naturally HL Liquid Hemorrhoid Relief Gel
Reason GMP Deviations: inadequate manufacturing control processes
Class II · Moderate risk Terminated
Extra Strength Naturally HL Hemorrhoid Numbing Spray with Lidocaine
Reason GMP Deviations: inadequate manufacturing control processes
Class II · Moderate risk Terminated
Extra Strength PreTAT by TAT BALM Gel
Reason GMP Deviations: inadequate manufacturing control processes
Class II · Moderate risk Terminated
Extra Strength Naturally HL Bed Sore Relief Cream with Added Lidocaine
Reason GMP Deviations: inadequate manufacturing control processes
Class II · Moderate risk Terminated
ePHEDrine Sulfate In 0.9% Sodium Chloride
Reason Subpotent Drug